Stockreport

Celanese Announces Commercial Launch of Glaukos' iDose® TR (Travoprost Intracameral Implant) Using Celanese's VitalDose® Ethylene Vinyl Acetate (EVA) [Yahoo! Finance]

Glaukos Corporation  (GKOS) 
Last glaukos corporation earnings: 2/27 04:15 pm Check Earnings Report
PDF of iDose ® TR by Glaukos Corporation using Celanese's VitalDose ® EVA to provide sustained drug release for the treatment of glaucoma. The majority of glaucoma and ocu [Read more]